Consistently, CPSF6 was overexpressed in stages I-VI of HCC (Figure S1C) and was highly expressed at the mRNA level in various cancer cell lines, including breast, liver, colon, and prostate cancers (Figure S1D). Here, CPSF6 is linked to hepatocellular carcinoma.